PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22658855 ↗2012Reported benefit

Bone marrow mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injuries via inactivation of the MEK/ERK signaling pathway in rats.

RatIschaemia-reperfusionHepaticSprague-DawleySystemic infusion via the tail vein

Model: 70% hepatic ischemia-reperfusion injury

Systemic MSC infusion significantly reduced liver enzyme release and improved histology of the acutely injured liver. MSC conditioned medium promoted hepatocyte proliferation and directly inhibited hydrogen peroxide induced apoptosis, with prevention of MEK/ERK pathway activation identified as pivo…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.